Can 'Baby Doses' of common drugs stop breast cancer with fewer side effects?
NCT ID NCT06364267
Summary
This study is testing whether very low doses of two existing breast cancer drugs, exemestane and tamoxifen, can help prevent breast cancer in postmenopausal women at high risk for the disease. The main goal is to see which low-dose option has a better impact on women's quality of life and causes fewer side effects over 12 months. About 140 participants will be randomly assigned to take one of the two medications, and neither they nor their doctors will know which one they are taking.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
E.O. Ospedali Galliera
RECRUITINGGenova, Italy, 16128, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.